Genpharmasec Limited (BOM:531592)

Genpharmasec Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	692	432	1,009	1,235	861	1,523
Market Cap Growth	-35.80%	-57.18%	-18.31%	43.41%	-43.45%	-31.34%
Enterprise Value	935	491	1,021	1,221	805	1,447
Last Close Price	1.25	0.78	1.89	2.23	1.87	3.30
PE Ratio	47.78	26.94	81.93	-	76.55	-
PS Ratio	0.48	0.30	2.99	4.06	3.38	5.57
PB Ratio	1.05	0.66	1.55	1.91	5.62	9.91
P/TBV Ratio	1.44	0.90	1.55	1.92	5.62	9.91
P/OCF Ratio	-	-	33.78	-	-	-
EV/Sales Ratio	0.65	0.34	3.03	4.01	3.15	5.30
EV/EBITDA Ratio	21.34	11.21	-	5926.15	300.20	-
EV/EBIT Ratio	42.28	22.20	-	31302.23	324.00	-
Debt / Equity Ratio	0.53	0.53	0.08	0.06	0.20	-
Debt / EBITDA Ratio	7.98	7.98	82.19	84.54	11.50	-
Net Debt / Equity Ratio	0.38	0.38	-0.01	-0.28	-0.04	-0.39
Net Debt / EBITDA Ratio	5.68	5.68	2.34	-868.31	-2.14	11.40
Net Debt / FCF Ratio	-1.38	-1.38	0.35	6.04	0.19	2.45
Asset Turnover	1.31	1.31	0.45	0.67	1.23	1.11
Inventory Turnover	12.18	12.18	3.99	2.93	2.75	4.22
Quick Ratio	0.84	0.84	2.02	11.58	4.54	2.02
Current Ratio	1.71	1.71	2.78	15.16	9.17	3.43
Return on Equity (ROE)	0.86%	0.86%	1.90%	-0.42%	7.33%	-1.16%
Return on Assets (ROA)	1.27%	1.27%	-0.62%	0.01%	0.75%	-1.35%
Return on Invested Capital (ROIC)	1.57%	1.65%	-0.88%	-0.01%	1.82%	-6.79%
Return on Capital Employed (ROCE)	2.40%	2.40%	-1.10%	0.00%	1.40%	-3.50%
Earnings Yield	2.32%	3.71%	1.22%	-0.14%	1.31%	-0.14%
FCF Yield	-26.11%	-41.84%	-2.70%	-2.40%	-3.57%	-1.59%
Buyback Yield / Dilution	-189.55%	-189.55%	-80.25%	-10.96%	-	-2.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.